As a neuroscientist and an associate professor in Concordia University’s psychology department, Nadia Chaudhri uses Twitter to stay in touch with colleagues and communicate about her research, which deals with how the brain contributes to behaviour in alcohol-use disorders. But the subject of her tweet on the morning of May 11 was something else entirely. “Today is the day I tell my son that I’m dying from cancer,” Chaudhri, 43, tweeted from a.
As a neuroscientist and an associate professor in Concordia University’s psychology department, Nadia Chaudhri uses Twitter to stay in touch with colleagues and communicate about her research, which deals with how the brain contributes to behaviour in alcohol-use disorders. But the subject of her tweet on the morning of May 11 was something else entirely. “Today is the day I tell my son that I’m dying from cancer,” Chaudhri, 43, tweeted from a.
“An ad you can’t miss, for a cancer you do.”
That is the tagline that appeared on billboards in Piccadilly Circus and Times Square, as part of a campaign to raise awareness of ovarian cancer organised by former North Otago woman Jane Ludemann.
Ms Ludemann (36), who founded the Cure Our Ovarian Cancer charity after her diagnosis with low-grade serous (LGS) ovarian cancer four years ago, organised the giant billboards to mark World Ovarian Cancer Day on May 8. They featured the faces of more than 30 women, including four New Zealanders, all also diagnosed with LGS ovarian cancer.
Ovarian cancer was a difficult reality to be faced with, but the women were all focused on providing better outcomes for them and others. New Zealand creative agency Topham Guerin helped with the campaign pro bono.
âDesperately disappointingâ setback for ovarian cancer screening hopes
Weâre sorry, this service is currently unavailable. Please try again later.
Dismiss
Save
Normal text size
Advertisement
Long-awaited results of a major ovarian cancer study three decades in the making found screening women detected the disease before they developed symptoms but didnât save lives.
The findings are a devastating blow for ovarian cancer researchers, patients and their supporters who had hoped the trial involving more than 200,000 women would lead to early diagnosis and ultimately national screening programs that would prevent thousands of ovarian cancer deaths every year.
Christy Smith was diagnosed with ovarian cancer in February 2020.